C

Caris Life Sciences Inc
NASDAQ:CAI

Watchlist Manager
Caris Life Sciences Inc
NASDAQ:CAI
Watchlist
Price: 28 USD -1.62% Market Closed
Market Cap: 7.9B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CAI.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CAI Intrinsic Value
Not Available
Base Case Scenario
Compare CAI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CAI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Caris Life Sciences Inc

Balance Sheet Decomposition
Caris Life Sciences Inc

Current Assets 854.2m
Cash & Short-Term Investments 755.5m
Receivables 26.7m
Other Current Assets 72.1m
Non-Current Assets 130.3m
PP&E 64m
Intangibles 19.3m
Other Non-Current Assets 47m
Current Liabilities 86m
Accounts Payable 29m
Accrued Liabilities 53.7m
Other Current Liabilities 3.3m
Non-Current Liabilities 420.2m
Long-Term Debt 376.3m
Other Non-Current Liabilities 43.9m
Efficiency

Free Cash Flow Analysis
Caris Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Caris Life Sciences Inc

Revenue
931.4m
Cost of Revenue
-432.7m
Gross Profit
498.7m
Operating Expenses
-799.1m
Operating Income
-300.4m
Other Expenses
-697.8m
Net Income
-998.2m
Fundamental Scores

CAI Profitability Score
Profitability Due Diligence

Caris Life Sciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Caris Life Sciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CAI Solvency Score
Solvency Due Diligence

Caris Life Sciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
hidden
Solvency
Score

Caris Life Sciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CAI Price Targets Summary
Caris Life Sciences Inc

Wall Street analysts forecast CAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CAI is 38.42 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.

Lowest
Price Target
28.28 USD
1% Upside
Average
Price Target
38.42 USD
37% Upside
Highest
Price Target
47.25 USD
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Caris Life Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CAI is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CAI Insider Trading
Buy and sell transactions by insiders